Kingworld Medicines Group Ltd
01110
Company Profile
Business description
Kingworld Medicines Group Ltd is engaged in the Distribution of pharmaceutical and healthcare products, such as branded imported pharmaceutical and healthcare products in Hong Kong and the PRC, and Manufacturing and sales of electrotherapeutic and physiotherapeutic devices and general medical examination devices carried out in the PRC. It derives the majority of its revenue from the Distribution sales of the pharmaceutical and healthcare products segment.
Contact
198 Daxin Road
8th-9th Floor, Block A, Majialong Chuangxin Building
Nanshan District, Guangdong Province
Shenzhen518016
CHNT: +86 75582292888
Sector
Healthcare
Stock type
Defensive
Industry
Pharmaceutical Retailers
Fiscal Year End
31 December 2026
Employees
732
Stocks News & Analysis
stocks
Going into earnings, is Microsoft stock a buy, a sell, or fairly valued?
Microsoft’s earnings report is expected to touch on AI adoption and monetization.
stocks
World’s largest miner overvalued after solid quarter
The ongoing war is likely to keep commodity prices even more volatile than usual until it is resolved.
stocks
Hidden value in an expensive ASX
How investors can uncover value beyond the index heavyweights.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,024.20 | 27.20 | -0.30% |
| CAC 40 | 8,211.24 | 54.81 | 0.67% |
| DAX 40 | 24,138.16 | 56.74 | -0.23% |
| Dow JONES (US) | 49,289.97 | 200.06 | -0.40% |
| FTSE 100 | 10,433.50 | 42.96 | -0.41% |
| HKSE | 25,915.20 | 248.04 | -0.95% |
| NASDAQ | 24,582.35 | 75.21 | -0.31% |
| Nikkei 225 | 59,140.23 | 445.63 | -0.75% |
| NZX 50 Index | 12,884.93 | 60.67 | -0.47% |
| S&P 500 | 7,124.59 | 13.31 | -0.19% |
| S&P/ASX 200 | 8,793.40 | 26.10 | -0.30% |
| SSE Composite Index | 4,093.25 | 13.01 | -0.32% |